Pathomechanisms: Homeostatic chemokines in health, tissue regeneration, and progressive diseases

Trends in Molecular Medicine

Volumn 20, Issue 3, 2014, Pages 154-165

  Anders, Hans Joachim ^a   Romagnani, Paola ^b   Mantovani, Alberto ^c,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FLORENCE   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemokine receptor; Inflammation; Malignancy; Regeneration; Tissue damage

Indexed keywords

CHEMOKINE RECEPTOR; INFLAMMATION; MALIGNANCY; REGENERATION; TISSUE DAMAGE;

BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CHEMOKINES; ENDOTHELIAL CELLS; HOMEOSTASIS; HUMANS; LYMPH NODES; LYMPHOCYTES; STEM CELLS; THYMUS GLAND; WOUND HEALING;

EID: 84894454703     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.12.002     Document Type: Review

References (106)

1. Wagers A.J. The stem cell niche in regenerative medicine. Cell Stem Cell 2012, 10:362-369.
2. Barker N., et al. Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell 2010, 7:656-670.
3. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 4:206-216.
4. Nomiyama H., et al. Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary history. Genes Cells 2013, 18:1-16.
5. Mortier A., et al. Overview of the mechanisms regulating chemokine activity and availability. Immunol. Lett. 2012, 145:2-9.
6. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392:565-568.
7. Randall T.D., et al. Development of secondary lymphoid organs. Annu. Rev. Immunol. 2008, 26:627-650.
8. Muller G., et al. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 2003, 195:117-135.
9. Nagasawa T., et al. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:2305-2309.
10. Broxmeyer H.E., et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J. Leukoc. Biol. 2003, 73:630-638.
11. Lee Y., et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood 2002, 99:4307-4317.
12. Wu W., et al. The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia 2012, 26:736-745.
13. Avigdor A., et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
14. Bachelerie, F. et al. (in press) New nomenclature for atypical chemokine receptor. Nat. Immunol.
15. Mazzinghi B., et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J. Exp. Med. 2008, 205:479-490.
16. Zou Y.R., et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
17. Ara T., et al. The role of CXCL12 in the organ-specific process of artery formation. Blood 2005, 105:3155-3161.
18. Takabatake Y., et al. The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J. Am. Soc. Nephrol. 2009, 20:1714-1723.
19. Ansel K.M., et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000, 406:309-314.
20. Britschgi M.R., et al. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19. Eur. J. Immunol. 2010, 40:1266-1271.
21. Forster R., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
22. Link A., et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 2007, 8:1255-1265.
23. Dona E., et al. Directional tissue migration through a self-generated chemokine gradient. Nature 2013, 503:285-289.
24. Rankin S.M. Chemokines and adult bone marrow stem cells. Immunol. Lett. 2012, 145:47-54.
25. Heissig B., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
26. Broxmeyer H.E., et al. Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann. N. Y. Acad. Sci. 1999, 872:142-163.
27. Ratajczak M.Z., et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010, 24:976-985.
28. Hernandez P.A., et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 2003, 34:70-74.
29. Martin C., et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003, 19:583-593.
30. Ma Q., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:9448-9453.
31. Broxmeyer H.E., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 2005, 201:1307-1318.
32. Kokovay E., et al. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell 2010, 7:163-173.
33. Berger O., et al. Expression of SDF-1 and CXCR4 during reorganization of the postnatal dentate gyrus. Dev. Neurosci. 2007, 29:48-58.
34. Bhattacharyya B.J., et al. The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J. Neurosci. 2008, 28:6720-6730.
35. Li M., et al. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci. 2012, 35:619-628.
36. Patel J.R., et al. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11062-11067.
37. Yang Q.E., et al. CXCL12-CXCR4 signaling is required for the maintenance of mouse spermatogonial stem cells. J. Cell Sci. 2013, 126:1009-1020.
38. Shahnazari M., et al. CXCL12/CXCR4 signaling in the osteoblast regulates the mesenchymal stem cell and osteoclast lineage populations. FASEB J. 2013, 27:3505-3513.
39. Hosogane N., et al. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int. J. Biochem. Cell Biol. 2010, 42:1132-1141.
40. Guang L.G., et al. Regulatory role of stromal cell-derived factor-1 in bone morphogenetic protein-2-induced chondrogenic differentiation in vitro. Int. J. Biochem. Cell Biol. 2012, 44:1825-1833.
41. Melchionna R., et al. Induction of myogenic differentiation by SDF-1 via CXCR4 and CXCR7 receptors. Muscle Nerve 2010, 41:828-835.
42. Ceradini D.J., Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 2005, 15:57-63.
43. Ceradini D.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10:858-864.
44. Olive M., et al. p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice. J. Clin. Invest. 2008, 118:2050-2061.
45. Togel F., et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 2005, 67:1772-1784.
46. Liehn E.A., et al. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J. Am. Coll. Cardiol. 2011, 58:2415-2423.
47. Abbott J.D., et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
48. Walter D.H., et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ. Res. 2005, 97:1142-1151.
49. Zernecke A., et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 2005, 96:784-791.
50. Bermudez D.M., et al. Inhibition of stromal cell-derived factor-1alpha further impairs diabetic wound healing. J. Vasc. Surg. 2011, 53:774-784.
51. Gallagher K.A., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J. Clin. Invest. 2007, 117:1249-1259.
52. Rabbany S.Y., et al. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant. 2010, 19:399-408.
53. Deshane J., et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J. Exp. Med. 2007, 204:605-618.
54. Inokuma D., et al. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes. Stem Cells 2006, 24:2810-2816.
55. Gomperts B.N., et al. Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J. Immunol. 2006, 176:1916-1927.
56. Zimmerman N.P., et al. Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution. Lab. Invest. 2011, 91:1040-1055.
57. Hu C., et al. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. J. Surg. Res. 2013, 183:427-434.
58. Abe R., et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 2001, 166:7556-7562.
59. Reich B., et al. Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int. 2013, 84:78-89.
60. Kitaori T., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009, 60:813-823.
61. Corsiero E., et al. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol. Lett. 2012, 145:62-67.
62. Balabanian K., et al. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J. Immunol. 2003, 170:3392-3400.
63. Cruz-Orengo L., et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 2011, 208:327-339.
64. Wei F., et al. Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway. Arthritis Res. Ther. 2012, 14:R177.
65. Zhang Z., et al. CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis. Exp. Eye Res. 2009, 89:522-531.
66. Momcilovic M., et al. CXCL12 in control of neuroinflammation. Immunol. Res. 2012, 52:53-63.
67. Ding M., et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat. Med. 2006, 12:1081-1087.
68. Phillips R.J., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004, 114:438-446.
69. Butler J.M., et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 2005, 115:86-93.
70. Darisipudi M.N., et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am. J. Pathol. 2011, 179:116-124.
71. Neusser M.A., et al. Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am. J. Pathol. 2010, 176:594-607.
72. Mantovani A., et al. Cancer-related inflammation. Nature 2008, 454:436-444.
73. Hermann P.C., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
74. Liang Z., et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 2004, 64:4302-4308.
75. Furusato B., et al. CXCR4 and cancer. Pathol. Int. 2010, 60:497-505.
76. Muller A., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
77. Kulbe H., et al. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 2007, 67:585-592.
78. Staller P., et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003, 425:307-311.
79. Vanharanta S., et al. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat. Med. 2013, 19:50-56.
80. Archibald K.M., et al. Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium. Oncogene 2012, 31:4987-4995.
81. Scotton C.J., et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002, 62:5930-5938.
82. Barbero S., et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 2003, 63:1969-1974.
83. Scala S., et al. Human melanoma metastases express functional CXCR4. Clin. Cancer Res. 2006, 12:2427-2433.
84. Huang Y.C., et al. Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells. Biochem. Pharmacol. 2007, 74:1702-1712.
85. Burger J.A., et al. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999, 94:3658-3667.
86. Monaco G., et al. Correlation between CXCR4 and homing or engraftment of acute myelogenous leukemia. Cancer Res. 2004, 64:6832-6833.
87. Mo W., et al. CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell 2013, 152:1077-1090.
88. Chen Y., et al. CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia. J. Clin. Invest. 2013, 123:2395-2407.
89. Shields J.D., et al. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 2010, 328:749-752.
90. Buonamici S., et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 2009, 459:1000-1004.
91. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004, 4:540-550.
92. Koizumi K., et al. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci. 2007, 98:1652-1658.
93. Flomenberg N., et al. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells. Acta Haematol. 2005, 114:198-205.
94. Uy G.L., et al. A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood 2012, 119:3917-3924.
95. Dale D.C., et al. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood 2011, 118:4963-4966.
96. Schulz-Knappe P., et al. HCC-1, a novel chemokine from human plasma. J. Exp. Med. 1996, 183:295-299.
97. Strasly M., et al. CCL16 activates an angiogenic program in vascular endothelial cells. Blood 2004, 103:40-49.
98. Bunting M.D., et al. CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity. Blood 2013, 121:118-128.
99. Morteau O., et al. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J. Immunol. 2008, 181:6309-6315.
100. Wurbel M.A., et al. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria. J. Immunol. 2007, 178:7598-7606.
101. Eslin D.E., et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 2004, 104:3173-3180.
102. Nagasawa T., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
103. Uehara S., et al. A role for CCR9 in T lymphocyte development and migration. J. Immunol. 2002, 168:2811-2819.
104. Sierro F., et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14759-14764.
105. Trentin L., et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004, 104:502-508.
106. Ding J., et al. Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). Wound Repair Regen. 2011, 19:568-578.